Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

Clinical trial NCT04884399 · COMPLETED

Trial details

NCT number: NCT04884399
Sponsor: Shanghai Biomabs Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Wet Age-related Macular Degeneration

Start date: 2021-06-03
Primary completion: 2022-12-22
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.